French death records reveal distinct drug risks for women and men

Sex Differences in Fatal Poisoning Among Drug Users in France: An Exploratory Analysis of the DRAMES Register.

Women's health issues : official publication of the Jacobs Institute of Women's Health • • Moderately Relevant
🤖

AI Summary

This exploratory study analyzed 6,068 drug-related deaths recorded in France between 2010 and 2023, including 1,120 women and 4,948 men. The researchers compared toxicology results, medical histories, and autopsy findings to identify differences in the substances involved in fatal poisonings. These findings describe associations in a death register; they do not show that any specific drug directly caused a higher risk of death in one sex.

Women had a higher proportion of deaths involving polydrug use than men (39.4% vs. 28.4%). Female deaths were significantly associated with several prescription medicines, including antidepressants, sedatives, codeine, and tramadol. Male deaths were significantly associated with cannabis, heroin, amphetamine-type stimulants, and other mostly illegal substances in France. For cannabis users, the results underscore the importance of avoiding combinations with other drugs and recognizing that the study does not establish whether cannabis itself caused these deaths. The authors call for prevention and treatment programs that address the specific needs of women with substance use disorders.

💡 Key Findings

1
Women had a significantly higher proportion of deaths involving polydrug use than men (39.4% vs. 28.4%).
High
80%
2
Female sex was associated with fatal poisonings involving several legal prescription medicines, including antidepressants, antipsychotics, benzodiazepines, codeine, and tramadol.
High
80%
3
Male sex was associated with deaths involving cannabis, heroin, amphetamine-type stimulants, and several other substances; the register data show an association, not proof that cannabis directly caused these deaths.
Good
75%
4
The authors conclude that prevention and care should include female-specific programs for people with substance use disorders.
High
80%

📄 Original Abstract

The DRAMES register (Décès en Relation avec l'Abus de Médicaments Et de Substances) is a French database of drug-related deaths reported by forensic toxicology experts. This study evaluated sex differences in the substances involved in deaths, with the aim of improving public policy on prevention and care for women with substance use disorders. We assessed 6,068 drug-related deaths that occurred from January 1, 2010, to December 31, 2023, in France (1,120 women [18.5%] with a mean age of 38 ± 11 years and 4,948 men [81.5%] with a mean age of 38 ± 10 years). Individual demographic characteristics and medical history, forensic autopsy findings, and toxicology reports were evaluated. The proportion of deaths related to polydrug use was higher in women than in men (39.4% vs. 28.4%; p < .001). Female sex was significantly associated with mortality from taking antidepressants (p < .001), antipsychotics (p < .001), benzodiazepines and z-drugs (p < .001), codeine (p = .002), other anxiolytics and hypnotics (p = .029), pholcodine (p = .005), and tramadol (p < .001), all of which are legal prescription medicines in France. Male sex was significantly associated with mortality from taking amphetamine-type stimulants (p = .044), buprenorphine (p = .042), cannabis (p < .001), gamma-hydroxybutyrate (p = .002), heroin (p < .001), and new psychoactive substances (p < .001). Apart from buprenorphine, all of these drugs are illegal in France. The observed differences in causes of death between women and men, specifically more polydrug related-deaths (especially with pharmaceuticals), highlight the need to address female-specific concerns. Further studies and resources are needed to develop programs dedicated to women with substance use disorders.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.